First the work of Carl June and his group of dedicated researchers, and now this from Penn’s Abramson Cancer Center: Researchers are now testing patients’ tumors for genetic mutations that could change their treatment options and decisions. Within the next couple of years, all patients at Penn’s cancer treatment center will receiving similar testing, which looks for up to 47 different mutations. Unfortunately, though, identifying those mutations is currently easier than actually treating them. But while Penn’s newest gamut of tests isn’t a cure for cancer, it does, in the words of Penn’s chief of medical oncology, Lynn Schuchter, count as a “huge leap forward.” [Philly.com]
- News: Penn Study: Glorious Utopian Future of Free Elite Online Education is a Bit of a Crock
- News: Study Confirms Effectiveness of Groundbreaking Penn Cancer Treatment
- Property: Locust Walk Wind Tunnel Claims Lives of 5 Umbrellas
- News: That Wind Tunnel on Locust Walk? Here’s Why It Happens.
- News: Inquirer Reporter’s Husband Dies After Penn Trial
- News: Buzz Bissinger to Lecture at Kelly Writers House